Cited by 79Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsNeuropeptides and Animal Physiology

Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray

Open access
Wilson-Poe, A.R., Morgan, M.M., Aicher, S.A., Hegarty, D.M.·2012·Neuroscience

Abstract

The periaqueductal gray (PAG) is part of a descending pain modulatory system that, when activated, produces widespread and profound antinociception. Microinjection of either opioids or cannabinoids into the PAG elicits antinociception. Moreover, microinjection of the cannabinoid 1 (CB1) receptor agonist HU-210 into the PAG enhances the antinociceptive effect of subsequent morphine injections, indicating a direct relationship between these two systems. The objective of this study was to characterize the distribution of CB1 receptors in the dorsolateral and ventrolateral PAG in relationship to mu-opioid peptide (MOP) receptors. Immunocytochemical analysis revealed extensive and diffuse CB1 receptor labeling in the PAG, 60% of which was found in somatodendritic profiles. CB1 and MOP receptor immunolabeling were co-localized in 32% of fluorescent Nissl-stained cells that were analyzed. Eight percent (8%) of PAG neurons that were MOP receptor-immunoreactive (-ir) received CB1 receptor-ir appositions. Ultrastructural analysis confirmed the presence of CB1 receptor-ir somata, dendrites and axon terminals in the PAG. These results indicate that behavioral interactions between cannabinoids and opioids may be the result of cellular adaptations within PAG neurons co-expressing CB1 and MOP receptors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuroscience.2012.03.038

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 62 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Wilson-Poe, A. R., Morgan, M. M., Aicher, S. A., & Hegarty, D. M.
Affiliations
  • Washington State University Vancouver (US)
  • Oregon Health & Science University (US)
Corresponding author
  • Morgan, M.M.
  • Aicher, S.A.
  • Hegarty, D.M.
Venue
Neuroscience
Publisher
Elsevier BV
Published
2012-06
Volume
213
Pages
191-200
ISSN
0306-4522 (ISSN-L)
OpenAlex
W2085789686
Cited by
79
References
62
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 8 · 2019: 5 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 2
FWCI
4.70
Type
journal article
Language
en
Open access
Locations
  • Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Drug Abuse (DA-011322, R01DA011322, R03DA026591, DA026591)
  • National Institute of Neurological Disorders and Stroke (P30NS061800)
  • National Institute of Dental and Craniofacial Research (DE012640, R01DE012640)
  • National Center for Research Resources (S10RR016858, RR-016858)
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords
CB1 receptor, mu-opioid receptor, periaqueductal gray, receptor colocalization, descending pain modulation, antinociception, morphine, HU-210, opioid-cannabinoid interaction, receptor ultrastructure
MeSH terms
Animals, Immunohistochemistry, Male, Neurons, Periaqueductal Gray, Rats, Sprague-Dawley, Receptors, Opioid, mu, Microscopy, Confocal, Receptor, Cannabinoid, CB1, Microscopy, Electron, Transmission, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review